Infective Endocarditis After Transcatheter Aortic Valve Implantation: A Systematic Review

Hassanin, Ahmed H.; Afify, Hesham; Zook, Salma; Frishman, William H.; Aronow, Wilbert S.

doi:10.1097/crd.0000000000000460

Cited by 3 publications

(2 citation statements)

References 32 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“… 32 , 33 In fact, IE is a rare but life-threatening complication after TAVI. A recent systematic review by Hassanin et al 34 demonstrated that most IE events after TAVI occur in the first year following TAVI. Age, sex, comorbid conditions, and procedural factors constitute the risk factors for IE and surgical intervention is seldom performed in this cohort.…”

Section: General Cardiac Surgery Scoresmentioning

confidence: 99%

Contemporary risk models for infective endocarditis surgery: a narrative review

Agrawal,

Arockiam,

Jamil

et al. 2023

Therapeutic Advances in Cardiovascular Disease

View full text Add to dashboard Cite

Infective endocarditis is a complex heterogeneous condition involving the infection of the endocardium and heart valves, leading to severe complications, including death. Surgery is often indicated in patients with infective endocarditis but is associated with elevated risk compared with other forms of cardiac surgery. Risk models play an important role in many cardiac surgeries as they can help inform clinicians and patients regarding procedural risk, decision-making to proceed or not, and influence perioperative management; however, they remain under-utilized in the infective endocarditis settings. Another crucial role of such risk models is to assess predicted versus found mortality, thereby allowing an assessment of institutional performance in infective endocarditis surgery. Traditionally, general cardiac surgery risk models such as European System for Cardiac Operative Risk Evaluation (EuroSCORE), EuroSCORE II, and Society of Thoracic Surgeon’s score have been applied to endocarditis surgery. However, there has been the development of many endocarditis surgery-specific scores over the last decade. This review aims to discuss clinical characteristics and applications of all contemporary risk scores in the setting of surgical treatment of infective endocarditis.

show abstract

Section: General Cardiac Surgery Scoresmentioning

confidence: 99%

Contemporary risk models for infective endocarditis surgery: a narrative review

Agrawal,

Arockiam,

Jamil

et al. 2023

Therapeutic Advances in Cardiovascular Disease

View full text Add to dashboard Cite

show abstract

“…Within the past year, there has been another interrogation of large databases looking for PVE after TAVR that mirrors these findings. Hassanin et al 2 searched PubMed and Embase and found 255,310 TAVR patients. PVE following TAVR had an incidence of 0.87–1.7 events per 100 person‐years.…”

mentioning

confidence: 99%

50+ years later, prosthetic valve endocarditis still confounds

Block

2023

Cathet Cardio Intervent

View full text Add to dashboard Cite

Ever since the introduction and surgical success of Starr-Edwards prostheses for valve replacement in the 1960s, prosthetic valve endocarditis (PVE) has plagued us. In the early 1970s, reports proliferated describing PVE and its complications, 1 and the concept of "early" and "late" PVE took shape. It became apparent that "early" PVE was generally due to infections related to the surgery itself or its attendant hospital stay.The organisms responsible were often Gram-positive or Gram-negative bad actors (staph and Pseudomonas) that were aggressive and/or antibiotic resistant, leading to poor outcomes. "Late" PVE that appeared months after surgery was often caused by more susceptible organisms that we associate with "subacute" endocarditis, such as streptococcus viridans. Intravenous antibiotic therapy and often surgical intervention was standard, but outcomes were never terrific.Fast forward to the report in this issue of CCI by Ogami and colleagues that used the National Readmission Database to chronicle patients that underwent transcatheter aortic valve replacement

show abstract